Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Osteoporos Int. 2020 Apr 1;31(8):1499–1506. doi: 10.1007/s00198-020-05372-6

Table 1. Base case deterministic cost-effectiveness results.

Usual management Screening Screening vs. usual management

Mean costs, per patient (£)
Hospitalisations 3,059 2,934 -125
Nursing home 6,056 5,645 -410
Outpatient 378 363 -15
Total morbidity cost 9,493 8,942 -551
Drugs 12 43 31
Treatment management 92 326 234
Total intervention cost 104 369 265
Total cost 9,596 9,310 -286
Effects, per patient
Life years 10.485 10.487 0.002
QALYs 7.359 7.374 0.015
Cost-effectiveness ratios
Cost/Life year Cost-saving
Cost/QALY Cost-saving